← Back to Screener
Canopy Growth Corporation Common Shares (CGC)
Price$1.08
Value ScoreB
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-19.78%
Price vs S&P 500 (4W)-6.29%
VGM Score44.23
Market Capitalization$471.44M
All Metrics
Book Value / Share (Quarterly)$1.49
P/TBV (Annual)0.70x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-19.22%
Cash Flow / Share (Quarterly)$-0.17
Price vs S&P 500 (YTD)-13.96%
Gross Margin (TTM)26.56%
Net Profit Margin (TTM)-117.31%
EPS (TTM)$-1.34
10-Day Avg Trading Volume1.67M
EPS Excl Extra (TTM)$-1.34
Revenue Growth (5Y)-7.57%
EPS (Annual)$-4.03
ROI (Annual)-73.62%
Gross Margin (Annual)30.30%
Net Profit Margin (5Y Avg)-327.43%
Cash / Share (Quarterly)$0.73
Revenue Growth QoQ (YoY)-0.29%
ROA (Last FY)-65.18%
Revenue Growth TTM (YoY)0.59%
EBITD / Share (TTM)$-0.19
ROE (5Y Avg)-143.17%
Operating Margin (TTM)-30.71%
Cash Flow / Share (Annual)$-0.70
P/B Ratio0.86x
P/B Ratio (Quarterly)0.77x
Net Income / Employee (Annual)$-451,615
EV / Revenue (TTM)1.92x
Net Interest Coverage (TTM)-0.29x
ROA (TTM)-32.67%
EV / EBITDA (TTM)116.12x
EPS Incl Extra (Annual)$-4.03
Current Ratio (Annual)3.12x
Quick Ratio (Quarterly)4.21x
3-Month Avg Trading Volume1.98M
52-Week Price Return-36.44%
Revenue / Employee (TTM)$210,222
Tangible BV / Share (Quarterly)$1.34
P/S Ratio (Annual)2.42x
Asset Turnover (Annual)0.29x
52-Week High$3.28
Operating Margin (5Y Avg)-253.07%
EPS Excl Extra (Annual)$-4.03
CapEx CAGR (5Y)-56.47%
Tangible BV CAGR (5Y)-38.24%
26-Week Price Return-3.85%
Quick Ratio (Annual)2.04x
13-Week Price Return-3.85%
Total Debt / Equity (Annual)0.67x
Current Ratio (Quarterly)5.34x
Enterprise Value$387.21M
Revenue / Share Growth (5Y)16.89%
Asset Turnover (TTM)0.28x
Book Value / Share Growth (5Y)-28.39%
Revenue / Employee (Annual)$203,118
Inventory Turnover (Annual)2.16x
Pretax Margin (Annual)-221.94%
Cash / Share (Annual)$0.52
3-Month Return Std Dev74.04%
Gross Margin (5Y Avg)0.76%
Net Income / Employee (TTM)$-246,612
ROE (Last FY)-122.76%
Net Interest Coverage (Annual)-0.34x
EPS Basic Excl Extra (Annual)$-4.03
Receivables Turnover (TTM)7.59x
Total Debt / Equity (Quarterly)0.34x
EPS Incl Extra (TTM)$-1.34
Receivables Turnover (Annual)5.82x
ROI (TTM)-35.91%
P/S Ratio (TTM)2.34x
Pretax Margin (5Y Avg)-315.56%
Revenue / Share (Annual)$1.81
Tangible BV / Share (Annual)$1.58
Price vs S&P 500 (52W)-64.65%
Year-to-Date Return-3.85%
5-Day Price Return-0.66%
EPS Normalized (Annual)$-4.03
ROA (5Y Avg)-56.25%
Net Profit Margin (Annual)-222.35%
Month-to-Date Return-0.66%
Cash Flow / Share (TTM)$-1.32
EBITD / Share (Annual)$-0.48
Operating Margin (Annual)-35.24%
LT Debt / Equity (Annual)0.62x
ROI (5Y Avg)-64.29%
LT Debt / Equity (Quarterly)0.30x
EPS Basic Excl Extra (TTM)$-1.34
P/TBV (Quarterly)0.86x
P/B Ratio (Annual)0.57x
Inventory Turnover (TTM)2.08x
Pretax Margin (TTM)-117.14%
Book Value / Share (Annual)$1.92
Price vs S&P 500 (13W)-13.59%
Beta2.07x
Revenue / Share (TTM)$0.58
ROE (TTM)-52.88%
52-Week Low$1.18
vGradeB
gGradeD
mGradeD
vgmGradeC
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.38
2.38
2.38
3.67
Industry Peers — Pharmaceutical Preparations(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CGCCanopy Growth Corporation Common Shares | B | D | D | $1.08 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $24.06 |
| CRONCronos Group Inc. Common Share | C | B | B | $2.82 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $5.49 |
| USNAUSANA Health Sciences Inc | B | D | D | $18.33 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.61 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.46 |
| ACBAurora Cannabis Inc. Common Shares | B | D | D | $3.64 |
| MDWDMediWound Ltd. | D | F | D | $13.82 |
| FTLFFitLife Brands, Inc. Common Stock | B | C | D | $9.91 |
| BTMDBiote Corp. Class A Common Stock | A | D | D | $2.11 |
About
Canopy Growth is a diversified cannabis producer offering medicinal and recreational products through a portfolio of brands including Doja, LivRelief, Ace Valley, and Deep Space. The company operates across four segments: Canadian cannabis (its primary revenue source), international markets, Storz & Bickel vaporizers, and This Works wellness products.